RT Journal Article
SR Electronic
T1 Oxpentifylline (trental) in peripheral arterial disease
JF Drug and Therapeutics Bulletin
JO Drug Ther Bull
FD BMJ Publishing Group Ltd
SP 59
OP 60
DO 10.1136/dtb.14.15.59
VO 14
IS 15
YR 1976
UL http://dtb.bmj.com/content/14/15/59.abstract
AB Vasodilators are disappointing in the treatment of peripheral vascular disease. There is little evidence that they either increase blood flow or improve symptoms.1 Oxpentifylline (Trental - Hoechst) is a dimethyl xanthine related to caffeine, theobromine and theophylline. It is a weak vasodilator, but the maker claims that it also reduces blood viscosity which is increased in patients with peripheral vascular disease.2 3